Assessment of Prokinetic Effects of Erythromycin in Emergency Patients With a Full Stomach
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The aims of the study is to assess whether the intravenous infusion of 3 mg/kg erythromycin has a significant gastrokinetic effect leading to empty the stomach in less than 90 minutes in non-fasting patients undergoing emergency trauma surgery.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
all trauma patients with a full stomach, undegoing emergency surgery
Emergency surgery for trauma
ASA 1 and 2 patients
Full stomach (antral area > 550 mm²)
No contraindication to erythromycin
Extreme emergency surgery (time frame < 90 min between arrival in the service and the start of the surgery)
gastroparesis or pathology associated with gastroparesis